Search research articles
Contact Us
Filters
Showing results (31-40 of 66) with videos related to
Page
of 7
Sort By:
Scientific Reports
|
August 25, 2017
RIPK1 protects hepatocytes from death in Fas-induced hepatitis
Aveline Filliol, Muhammad Farooq, Claire Piquet-Pellorce, et al.
Cell Death Discovery
|
June 10, 2025
Primidone: a clinically promising candidate for the treatment of psoriasis
Theresa Riebeling, Benedikt Kolbrink, Rebecca Philippsen, et al.
The Biochemical Journal
|
August 8, 2008
Apoptotic sensitivity of murine IAP-deficient cells
Julie M Rumble, Mathieu J M Bertrand, Rebecca A Csomos, et al.
Frontiers in Chemistry
|
April 24, 2023
From PERK to RIPK1: Design, synthesis and evaluation of novel potent and selective necroptosis inhibitors
Camilla Scarpellini, Sophie Valembois, Kenneth Goossens, et al.
Immunity
|
October 21, 2025
ATG9A-mediated autophagy prevents inflammatory skin disease by limiting TNFR1-driven STING activation and ZBP1-dependent cell death
Dario Priem, Jon Huyghe, Barbara Gilbert, et al.
Nature Protocols
|
July 15, 2016
A real-time fluorometric method for the simultaneous detection of cell death type and rate
Sasker Grootjans, Behrouz Hassannia, Iris Delrue, et al.
Cell Death & Disease
|
January 25, 2020
Correction: A20 protects cells from TNF-induced apoptosis through linear ubiquitin-dependent and -independent mechanisms
Dario Priem, Michael Devos, Sarah Druw, et al.
Journal of Hepatology
|
January 16, 2017
RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis
Aveline Filliol, Claire Piquet-Pellorce, Céline Raguénès-Nicol, et al.
Cell Death & Disease
|
September 20, 2019
A20 protects cells from TNF-induced apoptosis through linear ubiquitin-dependent and -independent mechanisms
Dario Priem, Michael Devos, Sarah Druwé, et al.
Biomedicines
|
May 28, 2022
The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach
Pauline Puylaert, Isabelle Coornaert, Cédric H G Neutel, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 66) with videos related to
Sort By:
Page
of 7
Scientific Reports
|
August 25, 2017
RIPK1 protects hepatocytes from death in Fas-induced hepatitis
Aveline Filliol, Muhammad Farooq, Claire Piquet-Pellorce, et al.
Cell Death Discovery
|
June 10, 2025
Primidone: a clinically promising candidate for the treatment of psoriasis
Theresa Riebeling, Benedikt Kolbrink, Rebecca Philippsen, et al.
The Biochemical Journal
|
August 8, 2008
Apoptotic sensitivity of murine IAP-deficient cells
Julie M Rumble, Mathieu J M Bertrand, Rebecca A Csomos, et al.
Frontiers in Chemistry
|
April 24, 2023
From PERK to RIPK1: Design, synthesis and evaluation of novel potent and selective necroptosis inhibitors
Camilla Scarpellini, Sophie Valembois, Kenneth Goossens, et al.
Immunity
|
October 21, 2025
ATG9A-mediated autophagy prevents inflammatory skin disease by limiting TNFR1-driven STING activation and ZBP1-dependent cell death
Dario Priem, Jon Huyghe, Barbara Gilbert, et al.
Nature Protocols
|
July 15, 2016
A real-time fluorometric method for the simultaneous detection of cell death type and rate
Sasker Grootjans, Behrouz Hassannia, Iris Delrue, et al.
Cell Death & Disease
|
January 25, 2020
Correction: A20 protects cells from TNF-induced apoptosis through linear ubiquitin-dependent and -independent mechanisms
Dario Priem, Michael Devos, Sarah Druw, et al.
Journal of Hepatology
|
January 16, 2017
RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis
Aveline Filliol, Claire Piquet-Pellorce, Céline Raguénès-Nicol, et al.
Cell Death & Disease
|
September 20, 2019
A20 protects cells from TNF-induced apoptosis through linear ubiquitin-dependent and -independent mechanisms
Dario Priem, Michael Devos, Sarah Druwé, et al.
Biomedicines
|
May 28, 2022
The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach
Pauline Puylaert, Isabelle Coornaert, Cédric H G Neutel, et al.
Page
of 7